nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—RARB—head and neck cancer	0.764	1	CbGaD
Acitretin—RBP1—tongue—head and neck cancer	0.00357	0.111	CbGeAlD
Acitretin—RBP1—hair follicle—head and neck cancer	0.00306	0.0947	CbGeAlD
Acitretin—Scleroderma—Docetaxel—head and neck cancer	0.00289	0.0347	CcSEcCtD
Acitretin—RARG—tongue—head and neck cancer	0.0027	0.0834	CbGeAlD
Acitretin—Isotretinoin—RARB—head and neck cancer	0.00264	0.368	CrCbGaD
Acitretin—Skin atrophy—Hydroxyurea—head and neck cancer	0.00249	0.0299	CcSEcCtD
Acitretin—RBP1—mouth—head and neck cancer	0.0024	0.0743	CbGeAlD
Acitretin—Carcinoma of lung—Docetaxel—head and neck cancer	0.00225	0.027	CcSEcCtD
Acitretin—Alitretinoin—RARB—head and neck cancer	0.00215	0.3	CrCbGaD
Acitretin—CYP26A1—trachea—head and neck cancer	0.00207	0.064	CbGeAlD
Acitretin—Lung neoplasm malignant—Docetaxel—head and neck cancer	0.00195	0.0234	CcSEcCtD
Acitretin—RXRG—neck—head and neck cancer	0.00186	0.0575	CbGeAlD
Acitretin—RARG—mouth—head and neck cancer	0.00181	0.0561	CbGeAlD
Acitretin—Scab—Fluorouracil—head and neck cancer	0.0017	0.0204	CcSEcCtD
Acitretin—Tretinoin—RARB—head and neck cancer	0.00152	0.211	CrCbGaD
Acitretin—Developmental delay—Fluorouracil—head and neck cancer	0.00142	0.0171	CcSEcCtD
Acitretin—Congenital anomaly—Fluorouracil—head and neck cancer	0.00142	0.0171	CcSEcCtD
Acitretin—RBP1—epithelium—head and neck cancer	0.0014	0.0432	CbGeAlD
Acitretin—Skin irritation—Fluorouracil—head and neck cancer	0.00125	0.015	CcSEcCtD
Acitretin—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.00125	0.015	CcSEcCtD
Acitretin—Blepharitis—Hydroxyurea—head and neck cancer	0.00122	0.0147	CcSEcCtD
Acitretin—Neuritis—Vinblastine—head and neck cancer	0.0011	0.0133	CcSEcCtD
Acitretin—Bullous eruption—Docetaxel—head and neck cancer	0.000988	0.0119	CcSEcCtD
Acitretin—RBP1—thyroid gland—head and neck cancer	0.000978	0.0302	CbGeAlD
Acitretin—Skin ulcer—Hydroxyurea—head and neck cancer	0.000965	0.0116	CcSEcCtD
Acitretin—RARB—thyroid gland—head and neck cancer	0.000905	0.028	CbGeAlD
Acitretin—Febrile neutropenia—Fluorouracil—head and neck cancer	0.000899	0.0108	CcSEcCtD
Acitretin—RXRA—head—head and neck cancer	0.000893	0.0276	CbGeAlD
Acitretin—RXRG—thyroid gland—head and neck cancer	0.000884	0.0274	CbGeAlD
Acitretin—Blepharitis—Fluorouracil—head and neck cancer	0.00088	0.0106	CcSEcCtD
Acitretin—Lacrimal disorder—Docetaxel—head and neck cancer	0.000873	0.0105	CcSEcCtD
Acitretin—RBP1—head—head and neck cancer	0.000867	0.0268	CbGeAlD
Acitretin—Bone pain—Vinblastine—head and neck cancer	0.00086	0.0103	CcSEcCtD
Acitretin—Raised liver function tests—Docetaxel—head and neck cancer	0.000846	0.0102	CcSEcCtD
Acitretin—Nail disorder—Fluorouracil—head and neck cancer	0.000834	0.01	CcSEcCtD
Acitretin—RXRB—thyroid gland—head and neck cancer	0.000831	0.0257	CbGeAlD
Acitretin—RARB—head—head and neck cancer	0.000803	0.0248	CbGeAlD
Acitretin—Creatinine increased—Hydroxyurea—head and neck cancer	0.00079	0.00948	CcSEcCtD
Acitretin—RXRG—head—head and neck cancer	0.000784	0.0243	CbGeAlD
Acitretin—Photophobia—Vinblastine—head and neck cancer	0.000774	0.00929	CcSEcCtD
Acitretin—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.000765	0.00919	CcSEcCtD
Acitretin—RARA—lymphoid tissue—head and neck cancer	0.000764	0.0236	CbGeAlD
Acitretin—RARG—thyroid gland—head and neck cancer	0.000738	0.0228	CbGeAlD
Acitretin—RXRB—head—head and neck cancer	0.000737	0.0228	CbGeAlD
Acitretin—Skin exfoliation—Hydroxyurea—head and neck cancer	0.000718	0.00862	CcSEcCtD
Acitretin—RARA—thyroid gland—head and neck cancer	0.000694	0.0215	CbGeAlD
Acitretin—Deafness—Vinblastine—head and neck cancer	0.000669	0.00803	CcSEcCtD
Acitretin—Haemorrhoids—Docetaxel—head and neck cancer	0.000664	0.00798	CcSEcCtD
Acitretin—RARG—head—head and neck cancer	0.000655	0.0203	CbGeAlD
Acitretin—Febrile neutropenia—Docetaxel—head and neck cancer	0.000649	0.00779	CcSEcCtD
Acitretin—Eye irritation—Fluorouracil—head and neck cancer	0.000634	0.00761	CcSEcCtD
Acitretin—RARA—head—head and neck cancer	0.000616	0.019	CbGeAlD
Acitretin—Cerebrovascular accident—Vinblastine—head and neck cancer	0.000611	0.00733	CcSEcCtD
Acitretin—Embolism—Docetaxel—head and neck cancer	0.000608	0.00731	CcSEcCtD
Acitretin—RBP1—lymph node—head and neck cancer	0.000607	0.0188	CbGeAlD
Acitretin—Nail disorder—Docetaxel—head and neck cancer	0.000602	0.00723	CcSEcCtD
Acitretin—Herpes simplex—Fluorouracil—head and neck cancer	0.000587	0.00705	CcSEcCtD
Acitretin—Cyst—Docetaxel—head and neck cancer	0.000584	0.00702	CcSEcCtD
Acitretin—Redness—Docetaxel—head and neck cancer	0.000578	0.00695	CcSEcCtD
Acitretin—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.000571	0.00686	CcSEcCtD
Acitretin—RARB—lymph node—head and neck cancer	0.000562	0.0174	CbGeAlD
Acitretin—Neuritis—Docetaxel—head and neck cancer	0.000523	0.00628	CcSEcCtD
Acitretin—Scotoma—Docetaxel—head and neck cancer	0.000514	0.00618	CcSEcCtD
Acitretin—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.000511	0.00614	CcSEcCtD
Acitretin—Rash erythematous—Docetaxel—head and neck cancer	0.00051	0.00612	CcSEcCtD
Acitretin—Photophobia—Fluorouracil—head and neck cancer	0.000508	0.0061	CcSEcCtD
Acitretin—Otitis media—Docetaxel—head and neck cancer	0.000502	0.00602	CcSEcCtD
Acitretin—Oesophagitis—Fluorouracil—head and neck cancer	0.000494	0.00594	CcSEcCtD
Acitretin—Pancytopenia—Vinblastine—head and neck cancer	0.000491	0.0059	CcSEcCtD
Acitretin—Ageusia—Docetaxel—head and neck cancer	0.000482	0.00579	CcSEcCtD
Acitretin—Rigors—Docetaxel—head and neck cancer	0.000478	0.00574	CcSEcCtD
Acitretin—Pancreatitis—Hydroxyurea—head and neck cancer	0.000462	0.00555	CcSEcCtD
Acitretin—Depression—Vinblastine—head and neck cancer	0.00046	0.00552	CcSEcCtD
Acitretin—RARG—lymph node—head and neck cancer	0.000458	0.0142	CbGeAlD
Acitretin—Eye irritation—Docetaxel—head and neck cancer	0.000457	0.00549	CcSEcCtD
Acitretin—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000452	0.00543	CcSEcCtD
Acitretin—Pancytopenia—Hydroxyurea—head and neck cancer	0.000448	0.00538	CcSEcCtD
Acitretin—Photosensitivity—Fluorouracil—head and neck cancer	0.000447	0.00537	CcSEcCtD
Acitretin—Dysuria—Hydroxyurea—head and neck cancer	0.000441	0.0053	CcSEcCtD
Acitretin—Vitamin A—CYP1A1—head and neck cancer	0.000441	0.0614	CrCbGaD
Acitretin—Bone disorder—Docetaxel—head and neck cancer	0.000432	0.00519	CcSEcCtD
Acitretin—RARA—lymph node—head and neck cancer	0.000431	0.0133	CbGeAlD
Acitretin—Weight increased—Hydroxyurea—head and neck cancer	0.000429	0.00515	CcSEcCtD
Acitretin—Tretinoin—CYP1A1—head and neck cancer	0.000426	0.0593	CrCbGaD
Acitretin—Haemoglobin—Vinblastine—head and neck cancer	0.000416	0.005	CcSEcCtD
Acitretin—Haemorrhage—Vinblastine—head and neck cancer	0.000414	0.00497	CcSEcCtD
Acitretin—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000412	0.00495	CcSEcCtD
Acitretin—Hypoaesthesia—Vinblastine—head and neck cancer	0.000412	0.00495	CcSEcCtD
Acitretin—Dermatitis bullous—Fluorouracil—head and neck cancer	0.000411	0.00493	CcSEcCtD
Acitretin—Pharyngitis—Vinblastine—head and neck cancer	0.000411	0.00493	CcSEcCtD
Acitretin—Stomatitis—Hydroxyurea—head and neck cancer	0.00041	0.00492	CcSEcCtD
Acitretin—Bone pain—Docetaxel—head and neck cancer	0.000408	0.0049	CcSEcCtD
Acitretin—Osteoarthritis—Fluorouracil—head and neck cancer	0.000393	0.00472	CcSEcCtD
Acitretin—Haemoglobin—Hydroxyurea—head and neck cancer	0.000379	0.00456	CcSEcCtD
Acitretin—Influenza like illness—Docetaxel—head and neck cancer	0.000379	0.00455	CcSEcCtD
Acitretin—Haemorrhage—Hydroxyurea—head and neck cancer	0.000377	0.00453	CcSEcCtD
Acitretin—Candida infection—Docetaxel—head and neck cancer	0.000373	0.00448	CcSEcCtD
Acitretin—Skin exfoliation—Docetaxel—head and neck cancer	0.000373	0.00448	CcSEcCtD
Acitretin—RARG—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000369	0.00326	CbGpPWpGaD
Acitretin—CYP26A1—Biological oxidations—GSTM1—head and neck cancer	0.000367	0.00325	CbGpPWpGaD
Acitretin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—BCL2—head and neck cancer	0.000367	0.00324	CbGpPWpGaD
Acitretin—Alopecia—Vinblastine—head and neck cancer	0.000366	0.00439	CcSEcCtD
Acitretin—CYP26A1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000362	0.0032	CbGpPWpGaD
Acitretin—Dry skin—Fluorouracil—head and neck cancer	0.00036	0.00432	CcSEcCtD
Acitretin—Oesophagitis—Docetaxel—head and neck cancer	0.000357	0.00428	CcSEcCtD
Acitretin—RARG—Retinoic acid receptors-mediated signaling—AKT1—head and neck cancer	0.000349	0.00308	CbGpPWpGaD
Acitretin—CYP26A1—Biological oxidations—CYP1A1—head and neck cancer	0.000348	0.00308	CbGpPWpGaD
Acitretin—Muscular weakness—Fluorouracil—head and neck cancer	0.000346	0.00416	CcSEcCtD
Acitretin—CYP26A1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000344	0.00303	CbGpPWpGaD
Acitretin—Angiopathy—Hydroxyurea—head and neck cancer	0.000342	0.00411	CcSEcCtD
Acitretin—Chills—Hydroxyurea—head and neck cancer	0.000339	0.00407	CcSEcCtD
Acitretin—RXRG—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000337	0.00298	CbGpPWpGaD
Acitretin—Ill-defined disorder—Vinblastine—head and neck cancer	0.000334	0.00401	CcSEcCtD
Acitretin—Alopecia—Hydroxyurea—head and neck cancer	0.000334	0.00401	CcSEcCtD
Acitretin—RARB—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000331	0.00292	CbGpPWpGaD
Acitretin—RXRA—PPARA activates gene expression—YAP1—head and neck cancer	0.000329	0.0029	CbGpPWpGaD
Acitretin—Erythema—Hydroxyurea—head and neck cancer	0.000329	0.00395	CcSEcCtD
Acitretin—RXRG—a6b1 and a6b4 Integrin signaling—EGFR—head and neck cancer	0.000325	0.00287	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—STAT6—head and neck cancer	0.000325	0.00287	CbGpPWpGaD
Acitretin—Malaise—Vinblastine—head and neck cancer	0.000325	0.0039	CcSEcCtD
Acitretin—Pancytopenia—Fluorouracil—head and neck cancer	0.000322	0.00387	CcSEcCtD
Acitretin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—YAP1—head and neck cancer	0.000322	0.00284	CbGpPWpGaD
Acitretin—RXRG—Retinoic acid receptors-mediated signaling—AKT1—head and neck cancer	0.000319	0.00282	CbGpPWpGaD
Acitretin—RARA—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000317	0.0028	CbGpPWpGaD
Acitretin—RXRB—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000317	0.0028	CbGpPWpGaD
Acitretin—Deafness—Docetaxel—head and neck cancer	0.000317	0.00381	CcSEcCtD
Acitretin—RXRA—PPAR Alpha Pathway—CCND1—head and neck cancer	0.000315	0.00278	CbGpPWpGaD
Acitretin—RARB—Retinoic acid receptors-mediated signaling—AKT1—head and neck cancer	0.000313	0.00276	CbGpPWpGaD
Acitretin—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00031	0.00372	CcSEcCtD
Acitretin—CYP26A1—Metabolism—UROD—head and neck cancer	0.000306	0.00271	CbGpPWpGaD
Acitretin—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—head and neck cancer	0.000306	0.0027	CbGpPWpGaD
Acitretin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000305	0.00366	CcSEcCtD
Acitretin—Discomfort—Vinblastine—head and neck cancer	0.000303	0.00364	CcSEcCtD
Acitretin—Hot flush—Docetaxel—head and neck cancer	0.000303	0.00364	CcSEcCtD
Acitretin—Menopausal symptoms—Docetaxel—head and neck cancer	0.0003	0.00361	CcSEcCtD
Acitretin—RXRA—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.0003	0.00265	CbGpPWpGaD
Acitretin—RXRB—Retinoic acid receptors-mediated signaling—AKT1—head and neck cancer	0.0003	0.00265	CbGpPWpGaD
Acitretin—RARA—Retinoic acid receptors-mediated signaling—AKT1—head and neck cancer	0.0003	0.00265	CbGpPWpGaD
Acitretin—Visual disturbance—Docetaxel—head and neck cancer	0.000299	0.00359	CcSEcCtD
Acitretin—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000297	0.00356	CcSEcCtD
Acitretin—Dermatitis bullous—Docetaxel—head and neck cancer	0.000297	0.00356	CcSEcCtD
Acitretin—Malaise—Hydroxyurea—head and neck cancer	0.000296	0.00356	CcSEcCtD
Acitretin—Stomatitis—Fluorouracil—head and neck cancer	0.000295	0.00354	CcSEcCtD
Acitretin—Urinary tract infection—Fluorouracil—head and neck cancer	0.000294	0.00353	CcSEcCtD
Acitretin—Conjunctivitis—Fluorouracil—head and neck cancer	0.000294	0.00353	CcSEcCtD
Acitretin—Epistaxis—Fluorouracil—head and neck cancer	0.000285	0.00343	CcSEcCtD
Acitretin—Sinusitis—Fluorouracil—head and neck cancer	0.000284	0.00341	CcSEcCtD
Acitretin—RXRG—a6b1 and a6b4 Integrin signaling—PIK3CA—head and neck cancer	0.000282	0.00249	CbGpPWpGaD
Acitretin—Anorexia—Vinblastine—head and neck cancer	0.00028	0.00337	CcSEcCtD
Acitretin—Migraine—Docetaxel—head and neck cancer	0.000279	0.00335	CcSEcCtD
Acitretin—Discomfort—Hydroxyurea—head and neck cancer	0.000276	0.00332	CcSEcCtD
Acitretin—RXRA—Biological oxidations—NAT2—head and neck cancer	0.000276	0.00244	CbGpPWpGaD
Acitretin—Haemoglobin—Fluorouracil—head and neck cancer	0.000273	0.00328	CcSEcCtD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—CDH1—head and neck cancer	0.000273	0.00241	CbGpPWpGaD
Acitretin—Rhinitis—Fluorouracil—head and neck cancer	0.000272	0.00327	CcSEcCtD
Acitretin—Haemorrhage—Fluorouracil—head and neck cancer	0.000272	0.00326	CcSEcCtD
Acitretin—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00027	0.00325	CcSEcCtD
Acitretin—Pharyngitis—Fluorouracil—head and neck cancer	0.00027	0.00324	CcSEcCtD
Acitretin—Oedema—Hydroxyurea—head and neck cancer	0.000268	0.00322	CcSEcCtD
Acitretin—RXRA—NRF2 pathway—TGFA—head and neck cancer	0.000268	0.00237	CbGpPWpGaD
Acitretin—Infection—Hydroxyurea—head and neck cancer	0.000266	0.0032	CcSEcCtD
Acitretin—RXRB—a6b1 and a6b4 Integrin signaling—PIK3CA—head and neck cancer	0.000265	0.00234	CbGpPWpGaD
Acitretin—Paraesthesia—Vinblastine—head and neck cancer	0.000264	0.00317	CcSEcCtD
Acitretin—Liver function test abnormal—Docetaxel—head and neck cancer	0.000262	0.00314	CcSEcCtD
Acitretin—RXRG—a6b1 and a6b4 Integrin signaling—HRAS—head and neck cancer	0.000261	0.00231	CbGpPWpGaD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	0.000261	0.0023	CbGpPWpGaD
Acitretin—Skin disorder—Hydroxyurea—head and neck cancer	0.00026	0.00313	CcSEcCtD
Acitretin—Dry skin—Docetaxel—head and neck cancer	0.00026	0.00312	CcSEcCtD
Acitretin—RARG—Generic Transcription Pathway—RARB—head and neck cancer	0.000258	0.00227	CbGpPWpGaD
Acitretin—Anorexia—Hydroxyurea—head and neck cancer	0.000256	0.00307	CcSEcCtD
Acitretin—Decreased appetite—Vinblastine—head and neck cancer	0.000256	0.00307	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000254	0.00224	CbGpPWpGaD
Acitretin—Pain—Vinblastine—head and neck cancer	0.000251	0.00302	CcSEcCtD
Acitretin—Constipation—Vinblastine—head and neck cancer	0.000251	0.00302	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00025	0.003	CcSEcCtD
Acitretin—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—head and neck cancer	0.000246	0.00217	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000244	0.00215	CbGpPWpGaD
Acitretin—RXRA—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000243	0.00215	CbGpPWpGaD
Acitretin—ALB—lymph node—head and neck cancer	0.000243	0.00752	CbGeAlD
Acitretin—Feeling abnormal—Vinblastine—head and neck cancer	0.000242	0.00291	CcSEcCtD
Acitretin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00024	0.00289	CcSEcCtD
Acitretin—Alopecia—Fluorouracil—head and neck cancer	0.00024	0.00288	CcSEcCtD
Acitretin—Somnolence—Hydroxyurea—head and neck cancer	0.000238	0.00286	CcSEcCtD
Acitretin—Erythema—Fluorouracil—head and neck cancer	0.000237	0.00284	CcSEcCtD
Acitretin—Dyspepsia—Hydroxyurea—head and neck cancer	0.000236	0.00283	CcSEcCtD
Acitretin—RXRG—Generic Transcription Pathway—RARB—head and neck cancer	0.000236	0.00208	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—YAP1—head and neck cancer	0.000234	0.00207	CbGpPWpGaD
Acitretin—Decreased appetite—Hydroxyurea—head and neck cancer	0.000233	0.0028	CcSEcCtD
Acitretin—Pancytopenia—Docetaxel—head and neck cancer	0.000233	0.00279	CcSEcCtD
Acitretin—Abdominal pain—Vinblastine—head and neck cancer	0.000232	0.00279	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000232	0.00205	CbGpPWpGaD
Acitretin—RXRA—Retinoic acid receptors-mediated signaling—MAPK3—head and neck cancer	0.000232	0.00205	CbGpPWpGaD
Acitretin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000232	0.00278	CcSEcCtD
Acitretin—Fatigue—Hydroxyurea—head and neck cancer	0.000231	0.00278	CcSEcCtD
Acitretin—RXRG—a6b1 and a6b4 Integrin signaling—AKT1—head and neck cancer	0.000231	0.00204	CbGpPWpGaD
Acitretin—Pain—Hydroxyurea—head and neck cancer	0.000229	0.00275	CcSEcCtD
Acitretin—Constipation—Hydroxyurea—head and neck cancer	0.000229	0.00275	CcSEcCtD
Acitretin—Weight increased—Docetaxel—head and neck cancer	0.000223	0.00268	CcSEcCtD
Acitretin—Vision blurred—Fluorouracil—head and neck cancer	0.000223	0.00268	CcSEcCtD
Acitretin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—head and neck cancer	0.000222	0.00196	CbGpPWpGaD
Acitretin—Weight decreased—Docetaxel—head and neck cancer	0.000222	0.00266	CcSEcCtD
Acitretin—RARA—Generic Transcription Pathway—RARB—head and neck cancer	0.000221	0.00196	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—RARB—head and neck cancer	0.000221	0.00196	CbGpPWpGaD
Acitretin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000221	0.00265	CcSEcCtD
Acitretin—RXRA—Retinoic acid receptors-mediated signaling—MAPK1—head and neck cancer	0.000221	0.00195	CbGpPWpGaD
Acitretin—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—head and neck cancer	0.000217	0.00192	CbGpPWpGaD
Acitretin—Hypersensitivity—Vinblastine—head and neck cancer	0.000217	0.0026	CcSEcCtD
Acitretin—RXRG—Generic Transcription Pathway—YAP1—head and neck cancer	0.000214	0.00189	CbGpPWpGaD
Acitretin—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000214	0.00257	CcSEcCtD
Acitretin—Stomatitis—Docetaxel—head and neck cancer	0.000213	0.00256	CcSEcCtD
Acitretin—Jaundice—Docetaxel—head and neck cancer	0.000213	0.00256	CcSEcCtD
Acitretin—Conjunctivitis—Docetaxel—head and neck cancer	0.000212	0.00255	CcSEcCtD
Acitretin—Body temperature increased—Hydroxyurea—head and neck cancer	0.000212	0.00255	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000211	0.00187	CbGpPWpGaD
Acitretin—Asthenia—Vinblastine—head and neck cancer	0.000211	0.00253	CcSEcCtD
Acitretin—RARB—Generic Transcription Pathway—YAP1—head and neck cancer	0.00021	0.00186	CbGpPWpGaD
Acitretin—Epistaxis—Docetaxel—head and neck cancer	0.000206	0.00247	CcSEcCtD
Acitretin—CYP26A1—Adipogenesis—STAT3—head and neck cancer	0.000202	0.00179	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—YAP1—head and neck cancer	0.000201	0.00178	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—YAP1—head and neck cancer	0.000201	0.00178	CbGpPWpGaD
Acitretin—Myalgia—Fluorouracil—head and neck cancer	0.000201	0.00242	CcSEcCtD
Acitretin—Chest pain—Fluorouracil—head and neck cancer	0.000201	0.00242	CcSEcCtD
Acitretin—Diarrhoea—Vinblastine—head and neck cancer	0.000201	0.00242	CcSEcCtD
Acitretin—Discomfort—Fluorouracil—head and neck cancer	0.000199	0.00239	CcSEcCtD
Acitretin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000198	0.00237	CcSEcCtD
Acitretin—Haemoglobin—Docetaxel—head and neck cancer	0.000197	0.00237	CcSEcCtD
Acitretin—Rhinitis—Docetaxel—head and neck cancer	0.000197	0.00236	CcSEcCtD
Acitretin—Hepatitis—Docetaxel—head and neck cancer	0.000196	0.00235	CcSEcCtD
Acitretin—Haemorrhage—Docetaxel—head and neck cancer	0.000196	0.00235	CcSEcCtD
Acitretin—Hypoaesthesia—Docetaxel—head and neck cancer	0.000195	0.00234	CcSEcCtD
Acitretin—Pharyngitis—Docetaxel—head and neck cancer	0.000195	0.00234	CcSEcCtD
Acitretin—Dizziness—Vinblastine—head and neck cancer	0.000194	0.00234	CcSEcCtD
Acitretin—Oedema peripheral—Docetaxel—head and neck cancer	0.000193	0.00232	CcSEcCtD
Acitretin—Oedema—Fluorouracil—head and neck cancer	0.000193	0.00232	CcSEcCtD
Acitretin—Asthenia—Hydroxyurea—head and neck cancer	0.000192	0.00231	CcSEcCtD
Acitretin—Infection—Fluorouracil—head and neck cancer	0.000192	0.0023	CcSEcCtD
Acitretin—Visual impairment—Docetaxel—head and neck cancer	0.000189	0.00227	CcSEcCtD
Acitretin—Vomiting—Vinblastine—head and neck cancer	0.000187	0.00225	CcSEcCtD
Acitretin—RXRA—PPARA activates gene expression—CYP1A1—head and neck cancer	0.000185	0.00163	CbGpPWpGaD
Acitretin—Headache—Vinblastine—head and neck cancer	0.000184	0.00221	CcSEcCtD
Acitretin—Anorexia—Fluorouracil—head and neck cancer	0.000184	0.00221	CcSEcCtD
Acitretin—Diarrhoea—Hydroxyurea—head and neck cancer	0.000183	0.0022	CcSEcCtD
Acitretin—Eye disorder—Docetaxel—head and neck cancer	0.000183	0.0022	CcSEcCtD
Acitretin—Flushing—Docetaxel—head and neck cancer	0.000182	0.00219	CcSEcCtD
Acitretin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—head and neck cancer	0.000181	0.0016	CbGpPWpGaD
Acitretin—Angiopathy—Docetaxel—head and neck cancer	0.000178	0.00214	CcSEcCtD
Acitretin—Dizziness—Hydroxyurea—head and neck cancer	0.000177	0.00213	CcSEcCtD
Acitretin—Immune system disorder—Docetaxel—head and neck cancer	0.000177	0.00213	CcSEcCtD
Acitretin—Chills—Docetaxel—head and neck cancer	0.000176	0.00211	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000176	0.00211	CcSEcCtD
Acitretin—Nausea—Vinblastine—head and neck cancer	0.000175	0.0021	CcSEcCtD
Acitretin—Insomnia—Fluorouracil—head and neck cancer	0.000175	0.0021	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000174	0.00153	CbGpPWpGaD
Acitretin—Paraesthesia—Fluorouracil—head and neck cancer	0.000173	0.00208	CcSEcCtD
Acitretin—Alopecia—Docetaxel—head and neck cancer	0.000173	0.00208	CcSEcCtD
Acitretin—Somnolence—Fluorouracil—head and neck cancer	0.000172	0.00206	CcSEcCtD
Acitretin—Erythema—Docetaxel—head and neck cancer	0.000171	0.00205	CcSEcCtD
Acitretin—Vomiting—Hydroxyurea—head and neck cancer	0.00017	0.00205	CcSEcCtD
Acitretin—Dyspepsia—Fluorouracil—head and neck cancer	0.00017	0.00204	CcSEcCtD
Acitretin—Rash—Hydroxyurea—head and neck cancer	0.000169	0.00203	CcSEcCtD
Acitretin—Dermatitis—Hydroxyurea—head and neck cancer	0.000169	0.00203	CcSEcCtD
Acitretin—Headache—Hydroxyurea—head and neck cancer	0.000168	0.00202	CcSEcCtD
Acitretin—Decreased appetite—Fluorouracil—head and neck cancer	0.000168	0.00202	CcSEcCtD
Acitretin—Dysgeusia—Docetaxel—head and neck cancer	0.000167	0.00201	CcSEcCtD
Acitretin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000167	0.002	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000166	0.00147	CbGpPWpGaD
Acitretin—RXRA—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000165	0.00146	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—SOD2—head and neck cancer	0.000165	0.00146	CbGpPWpGaD
Acitretin—Back pain—Docetaxel—head and neck cancer	0.000165	0.00198	CcSEcCtD
Acitretin—Pain—Fluorouracil—head and neck cancer	0.000165	0.00198	CcSEcCtD
Acitretin—Muscle spasms—Docetaxel—head and neck cancer	0.000164	0.00197	CcSEcCtD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—head and neck cancer	0.000159	0.00141	CbGpPWpGaD
Acitretin—Nausea—Hydroxyurea—head and neck cancer	0.000159	0.00191	CcSEcCtD
Acitretin—Feeling abnormal—Fluorouracil—head and neck cancer	0.000159	0.00191	CcSEcCtD
Acitretin—RXRA—Retinoic acid receptors-mediated signaling—AKT1—head and neck cancer	0.000156	0.00138	CbGpPWpGaD
Acitretin—RXRA—NRF2 pathway—GSTM1—head and neck cancer	0.000156	0.00137	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KISS1—head and neck cancer	0.000153	0.00136	CbGpPWpGaD
Acitretin—Urticaria—Fluorouracil—head and neck cancer	0.000153	0.00184	CcSEcCtD
Acitretin—RXRG—Adipogenesis—STAT3—head and neck cancer	0.000153	0.00135	CbGpPWpGaD
Acitretin—Body temperature increased—Fluorouracil—head and neck cancer	0.000153	0.00183	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000149	0.00132	CbGpPWpGaD
Acitretin—Cough—Docetaxel—head and neck cancer	0.000149	0.00179	CcSEcCtD
Acitretin—Myalgia—Docetaxel—head and neck cancer	0.000145	0.00175	CcSEcCtD
Acitretin—Chest pain—Docetaxel—head and neck cancer	0.000145	0.00175	CcSEcCtD
Acitretin—Arthralgia—Docetaxel—head and neck cancer	0.000145	0.00175	CcSEcCtD
Acitretin—RARA—Adipogenesis—STAT3—head and neck cancer	0.000144	0.00127	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000143	0.00126	CbGpPWpGaD
Acitretin—Hypersensitivity—Fluorouracil—head and neck cancer	0.000142	0.00171	CcSEcCtD
Acitretin—Dry mouth—Docetaxel—head and neck cancer	0.000142	0.00171	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000142	0.00125	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CEBPA—head and neck cancer	0.00014	0.00123	CbGpPWpGaD
Acitretin—Oedema—Docetaxel—head and neck cancer	0.000139	0.00167	CcSEcCtD
Acitretin—Infection—Docetaxel—head and neck cancer	0.000138	0.00166	CcSEcCtD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—PIK3CA—head and neck cancer	0.000138	0.00122	CbGpPWpGaD
Acitretin—Pruritus—Fluorouracil—head and neck cancer	0.000137	0.00164	CcSEcCtD
Acitretin—RXRA—Biological oxidations—GSTM1—head and neck cancer	0.000136	0.00121	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000136	0.0012	CbGpPWpGaD
Acitretin—Skin disorder—Docetaxel—head and neck cancer	0.000135	0.00163	CcSEcCtD
Acitretin—ALB—Folate Metabolism—SOD2—head and neck cancer	0.000134	0.00119	CbGpPWpGaD
Acitretin—Anorexia—Docetaxel—head and neck cancer	0.000133	0.00159	CcSEcCtD
Acitretin—Diarrhoea—Fluorouracil—head and neck cancer	0.000132	0.00159	CcSEcCtD
Acitretin—RXRA—Biological oxidations—CYP1A1—head and neck cancer	0.000129	0.00114	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—GPX1—head and neck cancer	0.000128	0.00113	CbGpPWpGaD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—head and neck cancer	0.000128	0.00113	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000128	0.00113	CbGpPWpGaD
Acitretin—Dizziness—Fluorouracil—head and neck cancer	0.000128	0.00153	CcSEcCtD
Acitretin—RXRA—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000128	0.00113	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—NAT2—head and neck cancer	0.000127	0.00112	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000127	0.00112	CbGpPWpGaD
Acitretin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000127	0.00152	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—GRP—head and neck cancer	0.000126	0.00112	CbGpPWpGaD
Acitretin—Insomnia—Docetaxel—head and neck cancer	0.000126	0.00151	CcSEcCtD
Acitretin—Paraesthesia—Docetaxel—head and neck cancer	0.000125	0.0015	CcSEcCtD
Acitretin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—head and neck cancer	0.000125	0.0011	CbGpPWpGaD
Acitretin—RARG—Gene Expression—RARB—head and neck cancer	0.000124	0.0011	CbGpPWpGaD
Acitretin—Somnolence—Docetaxel—head and neck cancer	0.000124	0.00149	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000123	0.00109	CbGpPWpGaD
Acitretin—Vomiting—Fluorouracil—head and neck cancer	0.000123	0.00147	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—STAT6—head and neck cancer	0.000123	0.00108	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000123	0.00108	CbGpPWpGaD
Acitretin—Dyspepsia—Docetaxel—head and neck cancer	0.000123	0.00147	CcSEcCtD
Acitretin—Rash—Fluorouracil—head and neck cancer	0.000122	0.00146	CcSEcCtD
Acitretin—Dermatitis—Fluorouracil—head and neck cancer	0.000122	0.00146	CcSEcCtD
Acitretin—Decreased appetite—Docetaxel—head and neck cancer	0.000121	0.00145	CcSEcCtD
Acitretin—Headache—Fluorouracil—head and neck cancer	0.000121	0.00145	CcSEcCtD
Acitretin—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00012	0.00144	CcSEcCtD
Acitretin—Fatigue—Docetaxel—head and neck cancer	0.00012	0.00144	CcSEcCtD
Acitretin—Pain—Docetaxel—head and neck cancer	0.000119	0.00143	CcSEcCtD
Acitretin—Constipation—Docetaxel—head and neck cancer	0.000119	0.00143	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000118	0.00105	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—RARB—head and neck cancer	0.000115	0.00102	CbGpPWpGaD
Acitretin—Feeling abnormal—Docetaxel—head and neck cancer	0.000115	0.00138	CcSEcCtD
Acitretin—Nausea—Fluorouracil—head and neck cancer	0.000115	0.00138	CcSEcCtD
Acitretin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000114	0.00137	CcSEcCtD
Acitretin—RXRA—Metabolism—UROD—head and neck cancer	0.000114	0.001	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—RARB—head and neck cancer	0.000113	0.001	CbGpPWpGaD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—head and neck cancer	0.000113	0.000998	CbGpPWpGaD
Acitretin—RARG—Gene Expression—YAP1—head and neck cancer	0.000113	0.000996	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—DPYD—head and neck cancer	0.000112	0.000985	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000112	0.000985	CbGpPWpGaD
Acitretin—Body temperature increased—Docetaxel—head and neck cancer	0.00011	0.00132	CcSEcCtD
Acitretin—Abdominal pain—Docetaxel—head and neck cancer	0.00011	0.00132	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—YAP1—head and neck cancer	0.000109	0.000959	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000107	0.000944	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000107	0.000943	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—RARB—head and neck cancer	0.000107	0.000942	CbGpPWpGaD
Acitretin—RARA—Gene Expression—RARB—head and neck cancer	0.000107	0.000942	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—YAP1—head and neck cancer	0.000106	0.000935	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000106	0.000933	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000105	0.000932	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—YAP1—head and neck cancer	0.000105	0.000927	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—YAP1—head and neck cancer	0.000103	0.000911	CbGpPWpGaD
Acitretin—Hypersensitivity—Docetaxel—head and neck cancer	0.000103	0.00123	CcSEcCtD
Acitretin—ALB—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000102	0.0009	CbGpPWpGaD
Acitretin—RARB—Gene Expression—YAP1—head and neck cancer	0.000101	0.000894	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000101	0.000893	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.0001	0.000886	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.0001	0.000886	CbGpPWpGaD
Acitretin—Asthenia—Docetaxel—head and neck cancer	0.0001	0.0012	CcSEcCtD
Acitretin—Pruritus—Docetaxel—head and neck cancer	9.86e-05	0.00118	CcSEcCtD
Acitretin—RXRB—Gene Expression—YAP1—head and neck cancer	9.7e-05	0.000857	CbGpPWpGaD
Acitretin—RARA—Gene Expression—YAP1—head and neck cancer	9.7e-05	0.000857	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—NOTCH1—head and neck cancer	9.66e-05	0.000853	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	9.62e-05	0.00085	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	9.62e-05	0.00085	CbGpPWpGaD
Acitretin—Diarrhoea—Docetaxel—head and neck cancer	9.53e-05	0.00114	CcSEcCtD
Acitretin—RARB—Generic Transcription Pathway—NOTCH1—head and neck cancer	9.47e-05	0.000837	CbGpPWpGaD
Acitretin—Dizziness—Docetaxel—head and neck cancer	9.21e-05	0.00111	CcSEcCtD
Acitretin—RARA—Generic Transcription Pathway—NOTCH1—head and neck cancer	9.08e-05	0.000802	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—NOTCH1—head and neck cancer	9.08e-05	0.000802	CbGpPWpGaD
Acitretin—Vomiting—Docetaxel—head and neck cancer	8.86e-05	0.00106	CcSEcCtD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.83e-05	0.00078	CbGpPWpGaD
Acitretin—Rash—Docetaxel—head and neck cancer	8.78e-05	0.00105	CcSEcCtD
Acitretin—Dermatitis—Docetaxel—head and neck cancer	8.78e-05	0.00105	CcSEcCtD
Acitretin—Headache—Docetaxel—head and neck cancer	8.73e-05	0.00105	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	8.71e-05	0.000769	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	8.68e-05	0.000766	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	8.43e-05	0.000744	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	8.35e-05	0.000738	CbGpPWpGaD
Acitretin—Nausea—Docetaxel—head and neck cancer	8.27e-05	0.000994	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	8.08e-05	0.000713	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—STAT3—head and neck cancer	7.51e-05	0.000663	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	7.45e-05	0.000658	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	7.12e-05	0.000628	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	7.07e-05	0.000625	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—IL2—head and neck cancer	7e-05	0.000618	CbGpPWpGaD
Acitretin—RBP1—Disease—NOTCH1—head and neck cancer	6.99e-05	0.000617	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	6.82e-05	0.000602	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	6.39e-05	0.000564	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—TYMS—head and neck cancer	6.36e-05	0.000561	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—GSTM1—head and neck cancer	6.28e-05	0.000555	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	6.17e-05	0.000545	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—GPX1—head and neck cancer	6.02e-05	0.000531	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—PTGS2—head and neck cancer	6e-05	0.00053	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—CYP1A1—head and neck cancer	5.96e-05	0.000526	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ATP7B—head and neck cancer	5.82e-05	0.000514	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	5.57e-05	0.000492	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—RARB—head and neck cancer	5.56e-05	0.000491	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	5.27e-05	0.000466	CbGpPWpGaD
Acitretin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	5.25e-05	0.000463	CbGpPWpGaD
Acitretin—ALB—Metabolism—UROD—head and neck cancer	5.19e-05	0.000458	CbGpPWpGaD
Acitretin—RBP1—Disease—PTGS2—head and neck cancer	5.19e-05	0.000458	CbGpPWpGaD
Acitretin—ALB—Platelet degranulation—VEGFA—head and neck cancer	5.1e-05	0.00045	CbGpPWpGaD
Acitretin—RARG—Gene Expression—NOTCH1—head and neck cancer	5.08e-05	0.000449	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—YAP1—head and neck cancer	5.06e-05	0.000447	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.02e-05	0.000443	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	5.02e-05	0.000443	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	5.01e-05	0.000443	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.97e-05	0.000439	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NOTCH1—head and neck cancer	4.89e-05	0.000432	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	4.86e-05	0.000429	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—NOTCH1—head and neck cancer	4.73e-05	0.000418	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NAT2—head and neck cancer	4.72e-05	0.000417	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—NOTCH1—head and neck cancer	4.65e-05	0.000411	CbGpPWpGaD
Acitretin—RARB—Gene Expression—NOTCH1—head and neck cancer	4.56e-05	0.000403	CbGpPWpGaD
Acitretin—RBP1—Disease—PTEN—head and neck cancer	4.53e-05	0.0004	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TP53—head and neck cancer	4.49e-05	0.000397	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NOTCH1—head and neck cancer	4.45e-05	0.000393	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—NOTCH1—head and neck cancer	4.37e-05	0.000386	CbGpPWpGaD
Acitretin—RARA—Gene Expression—NOTCH1—head and neck cancer	4.37e-05	0.000386	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	4.35e-05	0.000384	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	4.21e-05	0.000372	CbGpPWpGaD
Acitretin—RXRA—Metabolism—DPYD—head and neck cancer	4.14e-05	0.000366	CbGpPWpGaD
Acitretin—RBP1—Disease—STAT3—head and neck cancer	4.05e-05	0.000357	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.03e-05	0.000356	CbGpPWpGaD
Acitretin—RXRA—Metabolism—YAP1—head and neck cancer	3.93e-05	0.000347	CbGpPWpGaD
Acitretin—RBP1—Disease—MAPK3—head and neck cancer	3.87e-05	0.000341	CbGpPWpGaD
Acitretin—RBP1—Disease—MAPK1—head and neck cancer	3.68e-05	0.000325	CbGpPWpGaD
Acitretin—RBP1—Disease—EGFR—head and neck cancer	3.68e-05	0.000325	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.56e-05	0.000314	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTGS2—head and neck cancer	3.54e-05	0.000313	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL2—head and neck cancer	3.37e-05	0.000297	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CCND1—head and neck cancer	3.28e-05	0.00029	CbGpPWpGaD
Acitretin—RBP1—Disease—PIK3CA—head and neck cancer	3.19e-05	0.000282	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTEN—head and neck cancer	3.17e-05	0.00028	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTEN—head and neck cancer	3.09e-05	0.000273	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.95e-05	0.000261	CbGpPWpGaD
Acitretin—RBP1—Disease—HRAS—head and neck cancer	2.95e-05	0.000261	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VEGFA—head and neck cancer	2.86e-05	0.000253	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—STAT3—head and neck cancer	2.83e-05	0.00025	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MAPK3—head and neck cancer	2.81e-05	0.000248	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MAPK3—head and neck cancer	2.71e-05	0.000239	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IL2—head and neck cancer	2.66e-05	0.000235	CbGpPWpGaD
Acitretin—RBP1—Disease—AKT1—head and neck cancer	2.61e-05	0.00023	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—VEGFA—head and neck cancer	2.61e-05	0.00023	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—STAT3—head and neck cancer	2.58e-05	0.000228	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MAPK1—head and neck cancer	2.58e-05	0.000228	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.58e-05	0.000228	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EGFR—head and neck cancer	2.58e-05	0.000227	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MAPK3—head and neck cancer	2.57e-05	0.000227	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MAPK3—head and neck cancer	2.52e-05	0.000223	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MAPK3—head and neck cancer	2.46e-05	0.000218	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MAPK3—head and neck cancer	2.42e-05	0.000214	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MAPK3—head and neck cancer	2.42e-05	0.000214	CbGpPWpGaD
Acitretin—RXRA—Metabolism—TYMS—head and neck cancer	2.36e-05	0.000208	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MAPK1—head and neck cancer	2.34e-05	0.000207	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EGFR—head and neck cancer	2.34e-05	0.000207	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTM1—head and neck cancer	2.33e-05	0.000206	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.29e-05	0.000202	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NOTCH1—head and neck cancer	2.28e-05	0.000201	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.27e-05	0.0002	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	2.26e-05	0.0002	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CA—head and neck cancer	2.24e-05	0.000197	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GPX1—head and neck cancer	2.23e-05	0.000197	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP1A1—head and neck cancer	2.21e-05	0.000195	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CA—head and neck cancer	2.18e-05	0.000192	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—head and neck cancer	2.16e-05	0.000191	CbGpPWpGaD
Acitretin—ALB—Metabolism—NAT2—head and neck cancer	2.15e-05	0.00019	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	2.14e-05	0.000189	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HRAS—head and neck cancer	2.07e-05	0.000183	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	2.04e-05	0.00018	CbGpPWpGaD
Acitretin—RARG—Gene Expression—AKT1—head and neck cancer	1.9e-05	0.000168	CbGpPWpGaD
Acitretin—ALB—Metabolism—DPYD—head and neck cancer	1.89e-05	0.000167	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—HRAS—head and neck cancer	1.88e-05	0.000166	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—AKT1—head and neck cancer	1.83e-05	0.000161	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.82e-05	0.00016	CbGpPWpGaD
Acitretin—ALB—Metabolism—YAP1—head and neck cancer	1.79e-05	0.000158	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—AKT1—head and neck cancer	1.78e-05	0.000157	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	1.77e-05	0.000156	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—AKT1—head and neck cancer	1.74e-05	0.000153	CbGpPWpGaD
Acitretin—RARB—Gene Expression—AKT1—head and neck cancer	1.7e-05	0.00015	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—AKT1—head and neck cancer	1.66e-05	0.000147	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—AKT1—head and neck cancer	1.63e-05	0.000144	CbGpPWpGaD
Acitretin—RARA—Gene Expression—AKT1—head and neck cancer	1.63e-05	0.000144	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	1.44e-05	0.000127	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IL2—head and neck cancer	1.37e-05	0.000121	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.35e-05	0.000119	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTGS2—head and neck cancer	1.32e-05	0.000116	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MAPK3—head and neck cancer	1.26e-05	0.000111	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.17e-05	0.000104	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VEGFA—head and neck cancer	1.17e-05	0.000103	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTEN—head and neck cancer	1.15e-05	0.000101	CbGpPWpGaD
Acitretin—ALB—Hemostasis—MAPK3—head and neck cancer	1.1e-05	9.74e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—TYMS—head and neck cancer	1.08e-05	9.51e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTM1—head and neck cancer	1.06e-05	9.4e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—MAPK1—head and neck cancer	1.05e-05	9.27e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GPX1—head and neck cancer	1.02e-05	9e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP1A1—head and neck cancer	1.01e-05	8.91e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CA—head and neck cancer	9.1e-06	8.04e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—head and neck cancer	8.81e-06	7.78e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—AKT1—head and neck cancer	8.5e-06	7.51e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HRAS—head and neck cancer	8.42e-06	7.44e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.29e-06	7.32e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CA—head and neck cancer	8.09e-06	7.15e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—AKT1—head and neck cancer	7.44e-06	6.57e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AKT1—head and neck cancer	6.61e-06	5.84e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTGS2—head and neck cancer	6e-06	5.3e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTEN—head and neck cancer	5.23e-06	4.62e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CA—head and neck cancer	3.69e-06	3.26e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—AKT1—head and neck cancer	3.02e-06	2.66e-05	CbGpPWpGaD
